Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

4(57.1%)

N/A

2(28.6%)

Phase 3

1(14.3%)

7Total

Phase 1(4)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07363733Not ApplicableRecruiting

Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus

Role: lead

NCT06641154Phase 1Recruiting

Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)

Role: lead

NCT05678192Phase 1Completed

Effect of Menopausal Hormone Therapy on Immune System Parameters

Role: lead

NCT05737329Phase 1Unknown

Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency

Role: lead

NCT05490173Not ApplicableNot Yet Recruiting

The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants

Role: lead

NCT05455151Phase 1Completed

Hysteroscopic Injections of Autologous Endometrial Cells and Platelet-rich Plasma in Patients With Thin Endometrium

Role: lead

NCT05325749Unknown

Whole Exome Screening of Newborns

Role: lead

NCT03042741Phase 3Unknown

Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

Role: collaborator

All 8 trials loaded